Exoxemis as a Partner

Applying highest quality science, research, and development to our partnerships and collaborations.

Exoxemis is focused on the development of haloperoxidase enzyme-based products to address the increasing threat of serious and drug-resistant infections. We are committed to:

• Leveraging expertise in enzymology, bioanalytical methods, microbiology, and formulation sciences to bring new products to market.
• Applying highest quality science, research, and development to our partnerships and collaborations.
• Supporting scholarship and innovation in evolving applications of our technology.
• Targeting product opportunities to address areas of high, unmet clinical demand, and strong potential market growth.
• Extending the application of the myeloperoxidase and eosinophil peroxidase technology platform to a wide variety of medical, veterinary, agricultural, disinfectant, and industrial applications.
• Offering flexibility in formulation to accommodate multiple indications and provide a cGMP-manufactured product.
• Delivering value to partners and collaborators.